144 related articles for article (PubMed ID: 16315671)
1. Idiopathic thrombocytopenia in Cavalier King Charles Spaniels.
Singh MK; Lamb WA
Aust Vet J; 2005 Nov; 83(11):700-3. PubMed ID: 16315671
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic asymptomatic thrombocytopenia in Cavalier King Charles Spaniels is an autosomal recessive trait.
Pedersen HD; Häggstrom J; Olsen LH; Christensen K; Selin A; Burmeister ML; Larsen H
J Vet Intern Med; 2002; 16(2):169-73. PubMed ID: 11899033
[TBL] [Abstract][Full Text] [Related]
3. Comparison of methods for determining platelet numbers and volume in Cavalier King Charles spaniels.
Bertazzolo W; Comazzi S; Sesso L; Scarpa P; Ru G; Paltrinieri S
J Small Anim Pract; 2007 Oct; 48(10):556-61. PubMed ID: 17543023
[TBL] [Abstract][Full Text] [Related]
4. Comparison of manual and automated methods for determining platelet counts in dogs with macrothrombocytopenia.
Olsen LH; Kristensen AT; Qvortrup K; Pedersen HD
J Vet Diagn Invest; 2004 Mar; 16(2):167-70. PubMed ID: 15053372
[TBL] [Abstract][Full Text] [Related]
5. Plateletcrit is superior to platelet count for assessing platelet status in Cavalier King Charles Spaniels.
Tvedten H; Lilliehöök I; Hillström A; Häggström J
Vet Clin Pathol; 2008 Sep; 37(3):266-71. PubMed ID: 18761517
[TBL] [Abstract][Full Text] [Related]
6. Validation of Advia plateletcrit for assessing platelet mass in dogs, including Cavalier King Charles spaniels.
Tvedten HW; Lilliehöök IE; Oberg J; Häggström J; Höglund K; Ljungvall I
Vet Clin Pathol; 2012 Sep; 41(3):336-43. PubMed ID: 22954296
[TBL] [Abstract][Full Text] [Related]
7. Macrothrombocytosis in cavalier King Charles spaniels.
Brown SJ; Simpson KW; Baker S; Spagnoletti MA; Elwood CM
Vet Rec; 1994 Sep; 135(12):281-3. PubMed ID: 7817507
[TBL] [Abstract][Full Text] [Related]
8. Increased platelet aggregation response in Cavalier King Charles Spaniels with mitral valve prolapse.
Olsen LH; Kristensen AT; Häggström J; Jensen AL; Klitgaard B; Hansson H; Pedersen HD
J Vet Intern Med; 2001; 15(3):209-16. PubMed ID: 11380029
[TBL] [Abstract][Full Text] [Related]
9. Mutation in beta1-tubulin correlates with macrothrombocytopenia in Cavalier King Charles Spaniels.
Davis B; Toivio-Kinnucan M; Schuller S; Boudreaux MK
J Vet Intern Med; 2008; 22(3):540-5. PubMed ID: 18466252
[TBL] [Abstract][Full Text] [Related]
10. Decreased platelet function in Cavalier King Charles Spaniels with mitral valve regurgitation.
Tarnow I; Kristensen AT; Texel H; Olsen LH; Pedersen HD
J Vet Intern Med; 2003; 17(5):680-6. PubMed ID: 14529135
[TBL] [Abstract][Full Text] [Related]
11. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
[TBL] [Abstract][Full Text] [Related]
12. Giant platelet disorder in the Cavalier King Charles Spaniel.
Cowan SM; Bartges JW; Gompf RE; Hayes JR; Moyers TD; Snider CC; Gerard DA; Craft RM; Muenchen RA; Carroll RC
Exp Hematol; 2004 Apr; 32(4):344-50. PubMed ID: 15050744
[TBL] [Abstract][Full Text] [Related]
13. Platelet count and plateletcrit in Cavalier King Charles Spaniels and Greyhounds using the Advia 120 and 2120.
Kelley J; Sharkey LC; Christopherson PW; Rendahl A
Vet Clin Pathol; 2014 Mar; 43(1):43-9. PubMed ID: 24446765
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
Sudunagunta S; Green D; Christley R; Dukes-McEwan J
J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic, asymptomatic thrombocytopenia in Cavalier King Charles spaniels: 11 cases (1983-1993).
Smedile LE; Houston DM; Taylor SM; Post K; Searcy GP
J Am Anim Hosp Assoc; 1997; 33(5):411-5. PubMed ID: 9278116
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease.
Lu CC; Liu MM; Culshaw G; French A; Corcoran B
J Vet Cardiol; 2016 Jun; 18(2):100-9. PubMed ID: 26860643
[TBL] [Abstract][Full Text] [Related]
17. Urine 5-hydroxyindoleacetic acid in Cavalier King Charles spaniels with preclinical myxomatous mitral valve disease.
Christiansen LB; Cremer SE; Helander A; Madsen T; Reimann MJ; Møller JE; Höglund K; Ljungvall I; Häggström J; Olsen LH
Vet J; 2019 Aug; 250():36-43. PubMed ID: 31383418
[TBL] [Abstract][Full Text] [Related]
18. Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel.
Markby GR; Macrae VE; Corcoran BM; Summers KM
BMC Vet Res; 2020 Sep; 16(1):350. PubMed ID: 32967675
[TBL] [Abstract][Full Text] [Related]
19. Mitral valve prolapse in 3-year-old healthy Cavalier King Charles Spaniels. An echocardiographic study.
Pedersen HD; Kristensen BO; Lorentzen KA; Koch J; Jensen AL; Flagstad A
Can J Vet Res; 1995 Oct; 59(4):294-8. PubMed ID: 8548691
[TBL] [Abstract][Full Text] [Related]
20. A novel point mutation in the β1-tubulin gene in asymptomatic macrothrombocytopenic Norfolk and Cairn Terriers.
Gelain ME; Bertazzolo W; Tutino G; Pogliani E; Cian F; Boudreaux MK
Vet Clin Pathol; 2014 Sep; 43(3):317-21. PubMed ID: 25060661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
